123 related articles for article (PubMed ID: 37775359)
1. Reply to Fabian Falkenbach, Francesco Sanguedolce, and Lars Budäus's Letter to the Editor re: Elie Kaplan-Marans, Tenny R. Zhang, Jim C. Hu. Differing Recommendations on Prostate Biopsy Approach to Minimize Infections: An Examination of the European Association of Urology and American Urological Association Guidelines. Eur Urol. 2023;84:445-46.
Kaplan-Marans E; Zhang TR; Hu JC
Eur Urol; 2023 Dec; 84(6):e151. PubMed ID: 37775359
[No Abstract] [Full Text] [Related]
2. Re: Elie Kaplan-Marans, Tenny R. Zhang, Jim C. Hu. Differing Recommendations on Prostate Biopsy Approach to Minimize Infections: An Examination of the European Association of Urology and American Urological Association Guidelines. Eur Urol. 2023;84:445-46.
Falkenbach F; Sanguedolce F; Budäus L
Eur Urol; 2023 Dec; 84(6):e149-e150. PubMed ID: 37833175
[No Abstract] [Full Text] [Related]
3. Differing Recommendations on Prostate Biopsy Approach to Minimize Infections: An Examination of the European Association of Urology and American Urological Association Guidelines.
Kaplan-Marans E; Zhang TR; Hu JC
Eur Urol; 2023 Nov; 84(5):445-446. PubMed ID: 37296040
[TBL] [Abstract][Full Text] [Related]
4. Reply to Takeshi Takahashi's Letter to the Editor re: Hendrik Van Poppel, Monique J. Roobol, Christopher R. Chapple, et al. Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021. Eur Urol 2021;80:703-711: Would You Play a Russian Roulette-type Game of Prostate-specific Antigen Screening on Yourself?
Van Poppel H; Roobol MJ
Eur Urol; 2022 Jan; 81(1):e23-e24. PubMed ID: 34756628
[No Abstract] [Full Text] [Related]
5. Reply to Francesco Montorsi and Giorgio Gandaglia's Letter to the Editor re: Riccardo Autorino, Homayoun Zagar, Mirandolino B. Mariano, et al. Perioperative Outcomes of Robotic and Laparoscopic Simple Prostatectomy: A European-American Multi-institutional Analysis. Eur Urol 2015;68:86-94; Re: Matthew Bultitude, Ben Challacombe. Simple Prostatectomy: A Step Too Far for Laparoscopy? Eur Urol 2015;68:95-6. Eur Urol 2015;68:e7-8.
Autorino R; Zargar H; Porpiglia F
Eur Urol; 2015 Jul; 68(1):e9-10. PubMed ID: 25666848
[No Abstract] [Full Text] [Related]
6. Reply to Massimo Valerio, Mark Emberton, and Hashim U. Ahmed's Letter to the Editor re: Henk G. van der Poel, Roderick C.N. van den Bergh, Erik Briers, et al. Focal Therapy in Primary Localised Prostate Cancer: The European Association of Urology Position in 2018. Eur Urol 2018;74:84-91.
van der Poel HG; van den Bergh RCN; Briers E; Cornford P; Govorov A; Henry AM; Lam TB; Mason MD; Rouvière O; De Santis M; Wiegel T; Willemse PM; van Poppel H; Mottet N
Eur Urol; 2019 Feb; 75(2):e23-e24. PubMed ID: 30237024
[No Abstract] [Full Text] [Related]
7. Reply to Riccardo Bertolo's Letter to the Editor re: Giorgio Gandaglia, Carlo Andrea Bravi, Paolo Dell'Oglio, et al. The Impact of Implementation of the European Association of Urology Guidelines Panel Recommendations on Reporting and Grading Complications on Perioperative Outcomes after Robot-assisted Radical Prostatectomy. Eur Urol 2018;74:4-7.
Gandaglia G; Fossati N; Montorsi F; Briganti A
Eur Urol; 2018 Nov; 74(5):e116-e117. PubMed ID: 30007820
[No Abstract] [Full Text] [Related]
8. Reply to Yongbao Wei, Ruochen Zhang, and Le Lin's Letter to the Editor re: Börje Ljungberg, Laurence Albiges, Yasmin Abu-Ghanem, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. 2022;82:e88.
Ljungberg B; Bedke J; Capitanio U; Bex A
Eur Urol; 2022 Oct; 82(4):e111-e112. PubMed ID: 35773149
[No Abstract] [Full Text] [Related]
9. Reply to Yi Zhou, Weigang Yan, and Hanzhong Li's Letter to the Editor re: Eduard Baco, Erik Rud, Lars Magne Eri, et al. A Randomized Controlled Trial to Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy. Eur Urol 2016;69:149-56.
Baco E; Rud E; Vlatkovic L
Eur Urol; 2016 Aug; 70(2):e55. PubMed ID: 26852076
[No Abstract] [Full Text] [Related]
10. Reply to Francesco Montorsi, Giorgio Gandaglia, Alberto Briganti's Letter to the Editor, re: Veeru Kasivisvanathan, Armando Stabile, Joana B. Neves, et al. Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review, Meta-analysis. Eur Urol 2019;76:284-303: The choice of diagnostic test in prostate cancer is a balance of the risks and benefits: One size may not fit all.
Kasivisvanathan V; Takwoingi Y; Emberton M; Moore CM
Eur Urol; 2019 Nov; 76(5):e133-e134. PubMed ID: 31400949
[No Abstract] [Full Text] [Related]
11. Reply to Laurence Klotz's Letter to the Editor re: Jeremy Yeun-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of "Manels" in Major Urology Meetings. Eur Urol 2021;80:442-9. Eur Urol 2021;80:e100: Reply from the European Association of Urology Equity, Diversity, and Inclusion Task Force.
Carmen Mir M; Greenwell T; O'Kelly F; Proietti S; Laukhtina E; Mertens L; Morgenstern S; Ouzaid I;
Eur Urol; 2022 Jan; 81(1):e26-e27. PubMed ID: 34772550
[No Abstract] [Full Text] [Related]
12. Reply to E. David Crawford and Bo-Eric Persson's letter to the editor re: Giorgio Gandaglia, Maxine Sun, Jim C. Hu, et al. Gonadotropin-releasing hormone agonists and acute kidney injury in patients with prostate cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.01.026.
Gandaglia G; Sun M; Briganti A; Karakiewicz PI
Eur Urol; 2014 Aug; 66(2):e36-7. PubMed ID: 24746970
[No Abstract] [Full Text] [Related]
13. Reply to Piet R. Dirix, Carole Mercier, and Luc Y. Dirix's Letter to the Editor re: Fabian Lohaus, Klaus Zöphel, Steffen Löck, et al. Can Local Ablative Radiotherapy Revert Castration-resistant Prostate Cancer to an Earlier Stage of Disease? Eur Urol 2019;75:548-51.
Hölscher T; Lohaus F; Wirth M; Troost EGC
Eur Urol; 2019 Oct; 76(4):e103-e104. PubMed ID: 31256943
[No Abstract] [Full Text] [Related]
14. Reply to Michael Froehner, Manfred P. Wirth's letter to the editor re: Jim C. Hu, Giorgio Gandaglia, Pierre I. Karakiewicz, et al. Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control. Eur Urol 2014;66:666-72.
Hu JC
Eur Urol; 2014 Nov; 66(5):e86. PubMed ID: 24882671
[No Abstract] [Full Text] [Related]
15. Reply from authors re: Hebert Alberto Vargas, Hedvig Hricak. Magnetic resonance imaging-targeted prostate biopsies: now is the time to START. Eur Urol 2013;64:553-4: START: the beginning of a multidisciplinary effort to define the role of MRI-targeted Biopsy in the detection of clinically significant prostate cancer.
Moore CM; Kasivisvanathan V;
Eur Urol; 2013 Oct; 64(4):555-6. PubMed ID: 23856040
[No Abstract] [Full Text] [Related]
16. Reply to Yaxiong Tang, Xu Hu, Kan Wu, Yanxiang Shao, and Xiang Li's Letter to the Editor re: Umberto Capitanio, Jens Bedke, Laurence Albiges, et al. A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel. Eur Urol. 2022;83:3-5.
Capitanio U; Bedke J; Albiges L; Volpe A; Giles RH; Hora M; Marconi L; Klatte T; Abu-Ghanem Y; Dabestani S; Fernández Pello S; Hofmann F; Kuusk T; Campi R; Tahbaz R; Powles T; Ljungberg B; Bex A
Eur Urol; 2023 Mar; 83(3):e74-e75. PubMed ID: 36526491
[No Abstract] [Full Text] [Related]
17. Prostate Biopsy: Hyperbole and Misrepresentation Versus Scientific Evidence and Equipoise.
Mian BM
Eur Urol; 2024 Feb; 85(2):99-100. PubMed ID: 37328355
[TBL] [Abstract][Full Text] [Related]
18. Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2020;77:55-65: Assessing the Morbidity of Multimodal Approaches in Patients with Muscle-invasive Bladder Cancer.
Vetterlein MW; Gild P; Fisch M; Rink M
Eur Urol; 2020 Aug; 78(2):e77-e78. PubMed ID: 32376138
[No Abstract] [Full Text] [Related]
19. Reply to Laura Evangelista and Egesta Lopci's Letter to the Editor re: Hendrik Van Poppel, Renée Hogenhout, Peter Albers, et al. Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission. Eur Urol 2021;79:327-9: Early Detection of Prostate Cancer in High-risk Patients with Negative Fusion Biopsy.
Van Poppel H; Hogenhout R; Albers P; van den Bergh RCN; Barentsz JO; Roobol MJ
Eur Urol; 2021 Jul; 80(1):e28-e29. PubMed ID: 33965287
[No Abstract] [Full Text] [Related]
20. Reply to Yaalini Shanmugabavan, Stephanie Guillaumier and Hashim U. Ahmed's letter to the editor re: Morgan R. Pokorny, Maarten de Rooij, Earl Duncan, et al. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur Urol 2014;66:22-9.
Pokorny M; Van de Ven W; Barentsz J; Thompson L
Eur Urol; 2015 Mar; 67(3):e54-5. PubMed ID: 25194908
[No Abstract] [Full Text] [Related]
[Next] [New Search]
